# lung-cancer-exon20-analysis
**Project Objective:** To investigate Exon 20 mutations in lung cancers and identify mechanisms of drug resistance, new drug targets, and possible diagnostic biomarkers.

**Data Description:**
<table>
  <tr>
    <th>Dataset</th>
    <th>Description</th> 
    <th>Source</th>
  </tr>
  <tr>
    <td>GSE181673</td>
    <td>HER2 exon 20 insertion w/drug treatments, cell lines and PDXs</td>
    <td>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE188446</td> 
  </tr>
  <tr>
    <td>GSE188446</td>
    <td>HER2 exon 20 insertion drug treatment</td>
    <td>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE188446</td> 
  </tr>
   <tr>
    <td>GSE23768</td>
    <td>large dataset containing lung cancer patient sample RNA-Seq data</td>
    <td>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE23768</td> 
  </tr>
</table>
